ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
OSE Immunotherapeutics

OSE Immunotherapeutics (OSE)

7.38
0.32
( 4.53% )
Updated: 03:32:26

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.38
Bid
7.36
Ask
7.38
Volume
65,755
7.16 Day's Range 7.43
3.115 52 Week Range 11.58
Market Cap
Previous Close
7.06
Open
7.18
Last Trade
15
@
7.38
Last Trade Time
03:34:35
Financial Volume
-
VWAP
-
Average Volume (3m)
193,487
Shares Outstanding
21,767,777
Dividend Yield
-
PE Ratio
-6.98
Earnings Per Share (EPS)
-1.06
Revenue
2.23M
Net Profit
-23M

About OSE Immunotherapeutics

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Nantes, Loire-atlantique, Fra
Founded
-
OSE Immunotherapeutics is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker OSE. The last closing price for OSE Immunotherapeutics was 7.06 €. Over the last year, OSE Immunotherapeutics shares have traded in a share price range of 3.115 € to 11.58 €.

OSE Immunotherapeutics currently has 21,767,777 shares outstanding. The market capitalization of OSE Immunotherapeutics is 153.68 € million. OSE Immunotherapeutics has a price to earnings ratio (PE ratio) of -6.98.

OSE Latest News

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO Un abstract clinique sur les...

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO A clinical abstract on the induction results from the CoTikiS...

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé OSE Immunotherapeutics annonce des avancées cliniques...

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ARTEMIA: Clinical trial protocol approved globally. Most countries and sites...

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary...

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant...

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced...

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

OSE Immunotherapeutics Strengthens Leadership and Executive Committee OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE...

OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif

OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif Nantes, France, le 2 décembre 2024...

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 novembre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.233.216783216787.157.436.81049817.04754644DE
4-1.57-17.54189944138.9596.81449077.48640915DE
12-1.56-17.44966442958.9411.586.81934879.1595356DE
261.2820.98360655746.111.585.371864948.20526949DE
523.28804.111.583.1151709727.1509087DE
156-3.02-29.038461538510.411.582.7051072716.34323124DE
2603.74102.7472527473.6415.82.7051015657.4227915DE

OSE - Frequently Asked Questions (FAQ)

What is the current OSE Immunotherapeutics share price?
The current share price of OSE Immunotherapeutics is 7.38 €
How many OSE Immunotherapeutics shares are in issue?
OSE Immunotherapeutics has 21,767,777 shares in issue
What is the market cap of OSE Immunotherapeutics?
The market capitalisation of OSE Immunotherapeutics is EUR 153.68M
What is the 1 year trading range for OSE Immunotherapeutics share price?
OSE Immunotherapeutics has traded in the range of 3.115 € to 11.58 € during the past year
What is the PE ratio of OSE Immunotherapeutics?
The price to earnings ratio of OSE Immunotherapeutics is -6.98
What is the cash to sales ratio of OSE Immunotherapeutics?
The cash to sales ratio of OSE Immunotherapeutics is 72.14
What is the reporting currency for OSE Immunotherapeutics?
OSE Immunotherapeutics reports financial results in EUR
What is the latest annual turnover for OSE Immunotherapeutics?
The latest annual turnover of OSE Immunotherapeutics is EUR 2.23M
What is the latest annual profit for OSE Immunotherapeutics?
The latest annual profit of OSE Immunotherapeutics is EUR -23M
What is the registered address of OSE Immunotherapeutics?
The registered address for OSE Immunotherapeutics is 22 BOULEVARD DE BENONI GOULLIN, NANTES, LOIRE-ATLANTIQUE, 44200
What is the OSE Immunotherapeutics website address?
The website address for OSE Immunotherapeutics is www.ose-immuno.com
Which industry sector does OSE Immunotherapeutics operate in?
OSE Immunotherapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CFNCofina SGPS SA
15.90 €
(2,139.44%)
25
DMSBSDiagnostic Medical Systems
0.006 €
(200.00%)
1,000
NICBSNicox SA
0.0177 €
(35.11%)
20.71k
SEQUASequana medical NV
3.49 €
(26.45%)
951.31k
ATOAtos SE
0.0028 €
(21.74%)
1.31B
ALCYBCybergun
0.0001 €
(-50.00%)
1.46M
ALDMSDiagnostic Medical Systems
0.658 €
(-12.73%)
131.45k
ALNMRNamR SA
0.34 €
(-11.69%)
12.26k
ALPATPlant Advanced Technologies Pat
10.60 €
(-9.40%)
95
ALNEVNeovacs
1.10 €
(-8.62%)
600
ATOAtos SE
0.0028 €
(21.74%)
1.31B
NEOENNeoen SA
39.74 €
(0.51%)
81.29M
BCPBanco Comercial Portugues SA
0.4556 €
(1.02%)
21.42M
ALHPIHopium SA
0.005 €
(0.00%)
8.17M
ALTDTonner Drones
0.0118 €
(0.00%)
6.53M

Discussion

View Full Feed
Green doggie Green doggie 1 minute ago
Thanks, I hope you are right.
DRGV
TrendTrade2016 TrendTrade2016 5 minutes ago
RVSN BLOWING UP 1.40
RVSN
TrendTrade2016 TrendTrade2016 9 minutes ago
THE MONTHLY EXPLOSION
RGTI
TrendTrade2016 TrendTrade2016 10 minutes ago
CLOWNS GETTING SCHOOLED
RGTI
halldorson halldorson 11 minutes ago
I have been here since ADMD and hold several million shares - I am not a short seller at all and have even purchased and hold shares directly from the company from back in the day. This is a great company - great product in development and even a better product once it reaches the market. Often time
RDGL
TrendTrade2016 TrendTrade2016 11 minutes ago
RGTI BREAKING 17.00
RGTI
GREGG THE GREEK GREGG THE GREEK 12 minutes ago
Good morning !!!


Grabbed some CNEY last couple of days. Another one which looks like a nice pop should come our way.
CNEY
Golden Cross Golden Cross 12 minutes ago
$LITM 🎸 Rocking Early in the PM
LITM
Golden Cross Golden Cross 12 minutes ago
$LITM 🎸 Rocking Early in the PM
LITM
thistraderknowsall thistraderknowsall 15 minutes ago
ETH WOW Amazing!! BTC recovery to $100k was just out!!!!! And pro GRAVITY G to $1+ pSar.macd interesting developments!!
Enjoy!!
ETHUSD
weedtrader420 weedtrader420 15 minutes ago
☝️👔☝️
XRPUSD
thistraderknowsall thistraderknowsall 17 minutes ago
BTC Nice bounce up!!!! Also get GRAVITY G Great AI developments, it's going exponentially to $2 per news out!
BTCUSD
thistraderknowsall thistraderknowsall 18 minutes ago
#1 Crypto altcoin ..GRAVITY G Great AI it's going exponentially to $1 +
We win!!
TrendTrade2016 TrendTrade2016 22 minutes ago
QSI MONTHLY SAR FLIPPING AT 2.76
QSI
thistraderknowsall thistraderknowsall 23 minutes ago
#1 Crypto altcoin ..GRAVITY G Great AI it's going exponentially to $1 +
We win!!
thistraderknowsall thistraderknowsall 23 minutes ago
#1 Crypto altcoin ..GRAVITY G Great AI it's going exponentially to $1 +
We win!!
thistraderknowsall thistraderknowsall 24 minutes ago
#1 Crypto altcoin ..GRAVITY G Great AI it's going exponentially to $1 +
We win!!
TrendTrade2016 TrendTrade2016 26 minutes ago
QSI READY TO BREAK 3 BUCKS
QSI
TrendTrade2016 TrendTrade2016 28 minutes ago
QS GAPPING HARD
QS
PROPHET-of-PROFITS PROPHET-of-PROFITS 32 minutes ago
Perfect time for Telvantis to gain otciq access. See some filings uploaded and pk
RDAR
ElectricMountain53 ElectricMountain53 33 minutes ago
The so called industry experts here try to toss and turn their "knowledge" but in the meanwhile POET would have been the better investment so far, despite the lack of institutional ownership.. which obviously means nothing without revenue.
LWLG
TrendTrade2016 TrendTrade2016 35 minutes ago
RZLV BLOWING UP IN PRE
RZLV
TrendTrade2016 TrendTrade2016 36 minutes ago
RZLV HERES THE 5 BUCKS...MONSTER
RZLV
knrorrel knrorrel 36 minutes ago
$WIMI moving hard today and $QNCCF too
imho


$QNCCF (only 0.70) has been rising for two days and more and higher than all other Quantum stocks and this stock wants to see the dollar
🔥🔥🔥🔥🔥
and yesterday the next Quantu
QNCCF WIMI

Your Recent History

Delayed Upgrade Clock